Detalles de la búsqueda
1.
Algorithmic benchmark modulation: A novel method to develop success rates for clinical studies.
Clin Trials
; 21(2): 220-232, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38126256
2.
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
N Engl J Med
; 383(1): 35-48, 2020 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32579807
3.
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre-Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward.
Am J Respir Crit Care Med
; 205(3): 275-287, 2022 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34672872
4.
A randomized controlled trial of glycopyrrolate administered by metered dose inhaler in patients with uncontrolled asthma despite ICS/LABA treatment.
J Asthma
; 59(7): 1420-1432, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34338132
5.
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study.
Am J Respir Crit Care Med
; 203(5): 553-564, 2021 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33252985
6.
Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts.
Respir Res
; 22(1): 187, 2021 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34182998
7.
Association between COPD exacerbations and lung function decline during maintenance therapy.
Thorax
; 75(9): 744-753, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32532852
8.
Pharmacokinetics of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler formulated using co-suspension delivery technology after single and chronic dosing in patients with COPD.
Pulm Pharmacol Ther
; 60: 101873, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31841699
9.
The attributable estimand: A new approach to account for intercurrent events.
Pharm Stat
; 19(5): 626-635, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32198954
10.
The pharmacokinetics of three doses of budesonide/glycopyrronium/formoterol fumarate dihydrate metered dose inhaler compared with active controls: A Phase I randomized, single-dose, crossover study in healthy adults.
Pulm Pharmacol Ther
; 50: 11-18, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29544728
11.
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 8, 2017 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28061907
12.
Reply to López-Campos et al. and to Rogliani and Calzetta.
Am J Respir Crit Care Med
; 203(7): 927-928, 2021 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33444510
13.
Corrections to: Efficacy of budesonide/glycopyrronium/formoterol metered dose inhaler in patients with COPD: post-hoc analysis from the KRONOS study excluding patients with airway reversibility and high eosinophil counts.
Respir Res
; 22(1): 223, 2021 Aug 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34372834
14.
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
Respir Res
; 17(1): 109, 2016 09 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-27586537
15.
Randomized study of the safety, pharmacokinetics, and bronchodilatory efficacy of a proprietary glycopyrronium metered-dose inhaler in study patients with chronic obstructive pulmonary disease.
BMC Pulm Med
; 14: 118, 2014 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-25027304
16.
Comparability of critical quality attributes for establishing biosimilarity.
Stat Med
; 32(3): 462-9, 2013 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22903263
17.
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
Curr Med Res Opin
; 39(10): 1395-1405, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37583267
18.
Erratum to: A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 158, 2017 08 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-28826397
19.
Predictive modeling of COPD exacerbation rates using baseline risk factors.
Ther Adv Respir Dis
; 16: 17534666221107314, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35815359
20.
Benefits of Budesonide/Glycopyrronium/Formoterol Fumarate Dihydrate on COPD Exacerbations, Lung Function, Symptoms, and Quality of Life Across Blood Eosinophil Ranges: A Post-Hoc Analysis of Data from ETHOS.
Int J Chron Obstruct Pulmon Dis
; 17: 3061-3073, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36510486